Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFUL.L Regulatory News (FUL)

  • There is currently no data for FUL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

22 Mar 2017 07:00

RNS Number : 1433A
Fulham Shore PLC (The)
22 March 2017
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

The Fulham Shore plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation:

Mr Giuseppe Mascoli

4. Full name of shareholder(s)  (if different from 3.):

Rock (Nominees) Limited

5. Date of the transaction and date onwhich the threshold is crossed orreached:

20/03/17

6. Date on which issuer notified:

21/03/17

7. Threshold(s) that is/are crossed orreached:

Below 5%

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 

GB00B9F8VG44

 

30,589,746

30,589,746

28,537,246

28,537,246

4.99%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

28,537,246

4.99%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Giuseppe Mascoli

15. Contact telephone number:

020 3026 8560

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLDMGZFLMLGNZM
Date   Source Headline
29th Apr 20101:03 pmRNSForm 8.3 - [Fulcrum Pharma plc]
29th Apr 201011:48 amRNSForm 8.5 (EPT/RI)
29th Apr 20107:00 amRNSPosting of Offer Document
28th Apr 20107:00 amRNSHalf Yearly Report
28th Apr 20107:00 amRNSOffer by Gold Medal Acquisitions UK Limited
26th Apr 20104:41 pmRNSForm 8.3 - Fulcrum Pharma Plc
26th Apr 20108:21 amRNSForm 8.5 (EPT/RI)
20th Apr 201011:36 amRNSForm 8.5 (EPT/RI)
20th Apr 201010:27 amRNSForm 8.3 - FULCRUM PHARMA PLC
12th Apr 20108:45 amRNSEPT Disclosure
7th Apr 201010:32 amRNSEPT Disclosure
6th Apr 201010:03 amRNSEPT Disclosure
1st Apr 201010:46 amRNSEPT Disclosure
31st Mar 20108:37 amRNSEPT Disclosure
29th Mar 201010:01 amRNSEPT Disclosure
25th Mar 201012:39 pmRNSRule 8.3- Fulcrum Pharma
25th Mar 20109:35 amRNSEPT Disclosure
24th Mar 20109:35 amRNSEPT Disclosure
23rd Mar 201011:51 amRNSEPT Disclosure
17th Mar 20109:56 amRNSEPT Disclosure
11th Mar 201010:38 amRNSEPT Disclosure
10th Mar 201010:16 amRNSEPT Disclosure
19th Feb 201011:13 amRNSEPT Disclosure
18th Feb 201011:14 amRNSEPT Disclosure
9th Feb 20109:28 amRNSEPT Disclosure
5th Feb 20109:09 amRNSEPT Disclosure
3rd Feb 20108:38 amRNSEPT Disclosure
13th Jan 201010:05 amRNSRule 8.3- Fulcrum Pharma PLC
13th Jan 201010:04 amRNSEPT Disclosure
7th Jan 201010:37 amRNSEPT Disclosure
5th Jan 20109:21 amRNSEPT Disclosure
22nd Dec 200911:31 amRNSResult of AGM
19th Nov 200911:12 amRNSStatement re share price movement
12th Nov 20097:00 amRNSFinal Results
16th Jul 20094:31 pmRNSDirectors' Dealings / issue of options
8th Jun 20097:00 amRNSDirectorate Change
14th May 20097:00 amRNSHalf Yearly Report
23rd Dec 200812:34 pmRNSResult of AGM
24th Nov 20087:00 amRNSDirector/PDMR Shareholding
14th Nov 20087:00 amRNSCollaboration with Quantum Solutions
12th Nov 20087:00 amRNSFinal Results
26th Sep 20087:00 amRNSBoard Changes
12th Sep 20085:28 pmRNSDirector/PDMR Shareholding-Replacement
12th Sep 200811:40 amRNSDirector/PDMR Shareholding
2nd Sep 20087:00 amRNSAppointment of Director
5th Jun 20083:59 pmRNSDirector/PDMR Shareholding
22nd May 20087:00 amRNSInterim Results
10th Mar 20087:00 amRNSAppointment of new CEO
1st Feb 20084:10 pmRNSResult of AGM
22nd Jan 20087:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.